• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Syngene

    Emergent BioSolutions

    Aphena Pharma Solutions

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Cytovance Biologics

    Alcami

    Reed-Lane

    Flow Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    The New Horizon: Metaprise Analytics in Life Sciences

    Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team.

    The New Horizon: Metaprise Analytics in Life Sciences
    Related CONTENT
    • PCI Clinical Services to Host Seminars
    • Vertex Takes a Risk-based Approach to UAT
    • The New Horizon: Metaprise Analytics in Life Sciences
    • Boehringer, IBM Explore Blockchain Technology in Clinical Trials
    • Quanticate Launches QVigilance
    Michelle Longmire, MD, CEO and Founder, Medable05.07.19
    It is an incredible time to be a disruptor in life sciences. The current $2.6 billion dollars and 12 years to bring a drug to market is simply unacceptable and presents many opportunities for high impact innovation to enable effective therapies to reach patients faster and at lower cost.

    Why do clinical trials take so much time and cost so much money? In part, the answer lies in the sheer complexity of the challenge at hand. As a physician, I am very familiar with the enormous challenges of medical research. I often point out that clinical trials are the most complex form of healthcare. Unlike traditional medical care, in which healthcare is delivered and measured at the individual patient level, clinical trials aim to deliver standard or protocol-based healthcare to many patients in many clinics and often in many countries. Additionally, the critical outcomes must be measured precisely across diverse groups of patients and over considerable lengths of time. The “team” in a clinical trial expands far beyond the standard healthcare delivery model of doctor and patient to include clinical research coordinators, site and medical monitors, clinical research organizations, institutional review boards, and sponsors and regulators, to name a few. Simple modeling reveals that the clinical trial process is considerably more complex than traditional healthcare.

    Given this, bending the time-cost curve will come down to solutions that reduce complexity and introduce radical process efficiency into the clinical trial process. A favorite recent book recommendation by business process thought leader, Thomas H. Davenport, Competing on Analytics, highlights the power of enterprise analytics to unlock massive value. Looking at other industries, real-time enterprise analytics across complex processes collapse timelines and empowers stakeholders with the ability to act sooner. Enabling early and informed decision making empowers individuals and generates massive operational efficiency. According to Davenport, “These heralded—and coveted—applications amassed and applied data in ways that upended customer expectations and optimized operations to unprecedented degrees.” Additionally, with adoption, these technologies unlock a tremendous number of secondary benefits due to previously unrecognized bottlenecks and inefficiencies.

    I would argue that there is a critical new horizon, one beyond the enterprise analytics Davenport outlines. Unlike typical business processes, clinical trials involve individuals and processes that exist in separate enterprises. We must go beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team with real-time connections between all stakeholders.

    Wall Street is a particularly compelling model for the improvements we could unlock in clinical trials with metaprise analytics. Stock trading involves many individuals taking different actions that are highly interrelated and leverages a connected data ecosystem to empower these individuals to make real-time, high stakes decisions. Today’s Wall Street leverages several principles that are essential to reducing time and cost within complex systems: 1) data never stagnates, meaning that all data are analyzed in near real-time and 2) data is routed as either human essential and the actor is notified to make a data-driven decision or data is routed as human non-essential and processed by workflow automation. Algorithmic trading takes this a step further and removes the human decision making completely. Wall Street is merely one example of a metaprise data ecosystem.

    Where is the industry today? The answer is revealed by answering the simple question, does data stagnate?  Yes, and to an astonishing degree. Today, the majority of clinical trial data is captured on paper or entered into siloed databases. Where we have shifted from analog to digital, the mainstream technologies represent a form factor iteration rather than true transformation. To achieve metaprise analytics, we must move to intelligent systems that connect participants, clinicians, clinical monitors, data managers, CROs and sponsors so that data never stagnates and data undergoes evolving analysis to enable automation and highest quality decision making by both algorithms and humans in real-time.

    Metaprise analytics opens the door for quantitative analysis of data. Quantitative analysis leverages probabilistic modeling of data to enable high throughput transactions via automation and data driven decision making. In stock trading this is leveraged in “Quant Trading” to enable high throughput trading and quantitative risk analysis for buying and selling stocks. Similarly, one can imagine a similar process in trials. Such Quant Trials represent a next generation adaptive clinical trial where the trial is not only adapting based on data but the entire development process leverages quantitative analysis to remove all gut based decision making and to enable unprecedented optimization.

    The emergence of the “patient enterprise” is also driving the need for metaprise analytics. Increasingly, patients are insisting on direct data ownership. This phenomenon combined with the rising utilization of consumer data and consumer devices in healthcare is creating a true patient enterprise where the patient is a distinct entity with direct governance over an increasing number of data streams and data assets.


    Fundamental Principles of an Intelligent Clinical Trial Metaprise Platform
    • Harness Patient Enterprise
    • Connect all stakeholders
    • Automate data analytics - quantitative and qualitative
    • Automate workflows to optimize human capital
    • System-level transparency
    • Role based access
    • Zero data stagnation
    The application of metaprise analytics to clinical trials presents a massive opportunity to reduce time and cost required to get effective therapies to market. I predict that metaprise analytics will cut trial timelines in half, thereby radically reducing cost and getting effective therapies to patients much faster. The reductions in time will derive from eliminating data stagnation, decision making automating workflows and data processing, and enabling critical decision making in real-time.

    Beyond time and cost, a connected and intelligent data ecosystem will improve the quality of care delivered to patients. Enabling clinical teams to identify and respond to clinical events faster via analysis can improve trial safety for individual participants as well as entire study cohorts.


    Anticipated Benefits of Metaprise Analytics in Trials
    • Higher quality of patient care
    • Improvements in Safety
    • Higher quality data
    • Optimization of human capital
    • Accountability across stakeholders
    • Less time
    • Less money
    • Effective therapies to patients faster
    Our vision at Medable is ambitious and while there are semi-comparables such as my Wall Street example, the future we are building is distinctly different from today. In my journey from physician-scientist to tech entrepreneur, I have found it surprising how frequently we mistake change for progress and digitization for disruption. Currently, there is a lot of hype around digital, virtual, and data. But where is the impact? Transformation does not start with tech and this type of progress does not come from retrofit solutions, or iterative innovation. Transformation starts with a vision of a new horizon of possibility and is made real by a relentless drive to bring it to the world.

    References
    1. Sertkaya A, Wong HH, Jessup A, Beleche T. Key cost drivers of pharmaceutical clinical trials in the United States. Clin Trials. 2016 Apr;13(2):117-26.
    2. Thomas H Davenport; Jeanne G Harris. Competing on analytics : the new science of winning. Boston, Massachusetts : Harvard Business Review Press, ©2017

    Michelle Longmire MD, is Co-founder and Chief Executive Officer of Medable. Dr. Longmire is a Stanford-trained physician-entrepreneur dedicated to transforming healthcare through innovation. Dr. Longmire has a background in epigenetics, novel diagnostics, and imaging. She has published over 20 peer reviewed articles and holds patents in machine learning as applied to mobile health applications. Dr. Longmire founded Medable in 2014 to enable healthcare technology to be as seamless, integrated, and adaptive as the human body. Medable is transforming healthcare by enabling patient generated data to drive healthcare delivery, clinical research, and personalized and predictive medicine. www.medable.com
    Related Searches
    • patients
    • Clinical Trials
    • analytics
    • it
    Suggested For You
    PCI Clinical Services to Host Seminars PCI Clinical Services to Host Seminars
    Vertex Takes a Risk-based Approach to UAT Vertex Takes a Risk-based Approach to UAT
    The New Horizon: Metaprise Analytics in Life Sciences The New Horizon: Metaprise Analytics in Life Sciences
    Boehringer, IBM Explore Blockchain Technology in Clinical Trials Boehringer, IBM Explore Blockchain Technology in Clinical Trials
    Quanticate Launches QVigilance Quanticate Launches QVigilance
    Managing Outsourced Clinical Trials Managing Outsourced Clinical Trials
    Clinical Trial Innovation Summit: Patient-Centric Approaches to Data-Driven Clinical Trials Clinical Trial Innovation Summit: Patient-Centric Approaches to Data-Driven Clinical Trials
    Catalent Expands Shanghai Clinical Packaging Capabilities Catalent Expands Shanghai Clinical Packaging Capabilities
    “Clinically Speaking” “Clinically Speaking”
    Streamlining Drug Development: Streamlining Drug Development:

    Related Features

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20

    • Information Technology
      You Need Solutions, Digitization is the Answer

      You Need Solutions, Digitization is the Answer

      Cloud technology helps today’s contract manufacturers be agile, transparent and efficient.
      Brian Curran, Senior Vice President of Strategic Growth, MasterControl 10.14.20


    • Information Technology
      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      The proven promise and huge potential of using AI and ML to accelerate drug discovery.
      Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 11.20.19

    • Clinical Trials
      Gene Therapy Trials

      Gene Therapy Trials

      Applications and the limitations of real-world data.
      Karen Ooms, Executive Vice President and Head of Statistics, Quanticate 09.16.19

    • Information Technology
      A Brave New World of Data Integrity

      A Brave New World of Data Integrity

      How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
      Bob Voelkner, VP Sales and Marketing, LabVantage 06.13.19


    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19

    • Clinical Trials
      Clinical Trial Feasibility

      Clinical Trial Feasibility

      How to reduce late-stage trial risk with feasibility analysis
      Alan Scott and Denis McMillan, PAREXEL International 04.05.19

    • Clinical Trial Materials | Clinical Trials | Supply Chain
      Optimizing Clinical Supply Management

      Optimizing Clinical Supply Management

      IRT system design strategies to help life science companies cut drug wastage across clinical programs.
      Bart Nicholson, Director of Customer Success for IRT, CRF Bracket 04.05.19


    • Information Technology
      Industry 4.0 in the Pharma Industry

      Industry 4.0 in the Pharma Industry

      Digitization is not a single-handed project.
      Dr. Christian Hanisch, Project Manager Industry 4.0 Pharma, Bosch Packaging Technology 03.06.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19

    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19


    • Information Technology | Serialization | Supply Chain
      Serialization Compliance

      Serialization Compliance

      Automated data controls during packaging help improve compliance.
      Miguel Pitarch, Executive Director, Global Serialization, Bristol-Myers Squibb & the Bristol-Myers Squibb Serialization Team 11.13.18

    • Clinical Trial Materials | Information Technology
      Interactive Response Technology in Clinical Trial Supply

      Interactive Response Technology in Clinical Trial Supply

      Exploring the benefits of including IRT professionals earlier in trial planning
      Dave Holly, Senior Manager, IRT Development and Operations, Sharp Clinical Services 10.10.18

    • Clinical Trials | R&D
      Improving Pharma R&D Efficiency: The need to transform clinical trials

      Improving Pharma R&D Efficiency: The need to transform clinical trials

      Cost pressures on drug development are driving the search for savings and efficiencies—but efforts need to be integrated if t
      ICON plc 10.10.18

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • A New Era Of Vaccine And Biologic Drug Development
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login